The Charlson comorbidity index is adapted to predict costs of chronic disease in primary care patients

Journal of Clinical Epidemiology

Volumn 61, Issue 12, 2008, Pages 1234-1240

  Charlson, Mary E ^a   Charlson, Robert E ^b   Peterson, Janey C ^a   Marinopoulos, Spyridon S ^c   Briggs, William M ^d   Hollenberg, James P ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b YALE NEW HAVEN HOSPITAL   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d CENTRAL MICHIGAN UNIVERSITY   (United States)

Author keywords

Chronic disease; Comorbidity; Cost; Cost management; Prediction; Resource utilization

Indexed keywords

WARFARIN;

ARTICLE; CELLULITIS; CHRONIC DISEASE; COMORBIDITY; COMPUTER SYSTEM; DEPRESSION; HEALTH CARE COST; HOSPITAL COST; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MEDICAL INFORMATION SYSTEM; MEDICARE; PATIENT CARE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; SKIN ULCER;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHRONIC DISEASE; DRUG COSTS; EPIDEMIOLOGIC METHODS; FEMALE; HEALTH CARE COSTS; HEALTH RESOURCES; HEALTH SERVICES RESEARCH; HOSPITAL COSTS; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; NEW YORK CITY; PRIMARY HEALTH CARE; PROGNOSIS; YOUNG ADULT;

EID: 55249084180     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jclinepi.2008.01.006     Document Type: Article

References (36)

1. Anderson G., and Horvath J. The growing burden of chronic disease in America. Public Health Rep 119 (2004) 263-270
2. Maetzel A., Li L.C., Pencharz J., Tomlinson G., and Bombardier C. The economic burden associated with osteoarthritis, rheumatoid arthritis, and hypertension: a comparative study. Ann Rheum Dis 63 (2004) 395-401
3. Michaud K., Messer J., Choi H.K., and Wolfe F. Direct medical costs and their predictors in patients with rheumatoid arthritis: a three-year study of 7,527 patients. Arthritis Rheum 48 (2003) 2750-2762
4. Hogan P., Dall T., and Nikolov P. Economic costs of diabetes in the US in 2002. Diabetes Care 26 (2003) 917-932
5. Ettaro L., Songer T.J., Zhang P., and Engelgau M.M. Cost-of-illness studies in diabetes mellitus. Pharmacoeconomics 22 (2004) 149-164
6. Gordois A., Scuffham P., Shearer A., and Oglesby A. The health care costs of diabetic nephropathy in the United States and the United Kingdom. J Diabetes Complicat 18 (2004) 18-26
7. Dehkharghani S., Bible J., Chen J.G., Feldman S.R., and Fleischer Jr. A.B. The economic burden of skin disease in the United States. J Am Acad Dermatol 48 (2003) 592-599
8. Gendo K., Sullivan S.D., Lozano P., Finkelstein J.A., Fuhlbrigge A., and Weiss K.B. Resource costs for asthma-related care among pediatric patients in managed care. Ann Allergy Asthma Immunol 91 (2003) 251-257
9. Cisternas M.G., Blanc P.D., Yen I.H., Katz P.P., Earnest G., Eisner M.D., et al. A comprehensive study of the direct and indirect costs of adult asthma. J Allergy Clin Immunol 111 (2003) 1212-1218
10. Flack J.M., Casciano R., Casciano J., Doyle J., Arikian S., Tang S., et al. Cardiovascular disease costs associated with uncontrolled hypertension. Manag Care Interface 15 11 (2002) 28-36
11. Katon W.J., Lin E., Russo J., and Unutzer J. Increased medical costs of a population-based sample of depressed elderly patients. Arch Gen Psychiatry 60 (2003) 897-903
12. Druss B.G., and Rosenheck R.A. Patterns of health care costs associated with depression and substance abuse in a national sample. Psychiatr Serv 50 (1999) 214-218
13. Simon G., Ormel J., VonKorff M., and Barlow W. Health care costs associated with depressive and anxiety disorders in primary care. Am J Psychiatry 152 (1995) 352-357
14. Fishman P., Von Korff M., Lozano P., and Hecht J. Chronic care costs in managed care. Health Aff (Millwood) 16 (1997) 239-247
15. Ray G.T., Collin F., Lieu T., Fireman B., Colby C.J., Quesenberry C.P., et al. The cost of health conditions in a health maintenance organization. Med Care Res Rev 57 (2000) 92-109
16. Yu W., Ravelo A., Wagner T.H., Phibbs C.S., Bhandari A., Chen S., et al. Prevalence and costs of chronic conditions in the VA health care system. Med Care Res Rev 60 3 Suppl (2003) 146S-167S
17. van Vliet R.C., and van de Ven W.P. Capitation payments based on prior hospitalizations. Health Econ 2 (1993) 177-188
18. Weiner J.P., Dobson A., Maxwell S.L., Coleman K., Starfield B., and Anderson G.F. Risk-adjusted Medicare capitation rates using ambulatory and inpatient diagnoses. Health Care Financ Rev 17 (1996) 77-99
19. Meenan R.T., Goodman M.J., Fishman P.A., Hornbrook M.C., O'Keeffe-Rosetti M.C., and Bachman D.J. Using risk-adjustment models to identify high-cost risks. Med Care 41 (2003) 1301-1312
20. Charlson M.E., Pompei P., Ales K.L., and MacKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40 (1987) 373-383
21. Shwartz M., Iezzoni L.I., Moskowitz M.A., Ash A.S., and Sawitz E.B. The importance of comorbidities in explaining differences in patient costs. Med Care 34 (1996) 767-782
22. Deyo R.A., Cherkin D.C., and Ciol M.A. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 45 (1992) 613-619
23. Wong M.D., Hollenberg J.P., and Charlson M.E. A comparison of clinical performance of primary care and traditional internal medicine residents. Med Care 37 (1999) 773-784
24. R Development Core Team. R: A language and environment for statistical computing (2004), R Foundation for Statistical Computing, Vienna, Austria. http://www.R-project.org.d environment for statistical computing
25. Tierney W.M., Fitzgerald J.F., Miller M.E., James M.K., and McDonald C.D. Predicting inpatient costs with admitting clinical data. Med Care 33 (1995) 1-14
26. Fowles J.B., Weiner J.P., Knutson D., Fowler E., Tucker A.M., and Ireland M. Taking health status into account when setting capitation rates: a comparison of risk-adjustment methods. JAMA 276 16 (1996) 1316-1321
27. Ellis R.P., Pope G.C., Iezzoni L., Ayanian J.Z., Bates D.W., Burstin H., et al. Diagnosis-based risk adjustment for Medicare capitation payments. Health Care Financ Rev 17 (1996) 101-128
28. Ash A.S., Ellis R.P., Pope G.C., Ayanian J.Z., Bates D.W., Burstin H., et al. Using diagnoses to describe populations and predict costs. Health Care Financ Rev 21 3 (2000) 7-28
29. Newhouse J.P., Manning W.G., Keeler E.B., and Sloss M.M. Adjusting capitation rates using objective health measures and prior utilization. Health Care Financ Rev 10 3 (1989) 41-54
30. Wolff J.L., Starfield B., and Anderson G. Prevalence, expenditures, and complications of multiple chronic conditions in the elderly. Arch Intern Med 162 20 (2002) 2269-2276
31. Newhouse J.P. Reimbursing health plans and health providers: efficiency in production versus selection. J Econ Lit 34 (1996) 1236-1263
32. Vliet Rv. Predictability of individual health care expenditures. J Risk Insur 59 (1992) 443-461
33. Roos L.L., Mustard C.A., Nicol J.P., McLerran D.F., Malenka D.J., Young T.K., et al. Registries and administrative data: organization and accuracy. Med Care 31 (1993) 201-212
34. Epstein A.M., and Cumella E.J. Capitation payment: using predictors for medical utilization to adjust rates. Health Care Financ Rev 10 (1988) 51-69
35. Cox C. Physician utilization by three groups of ethnic elderly. Med Care 24 (1986) 667-676
36. Pappas G., Hadden W.C., Kozak L.J., and Fisher G.F. Potentially avoidable hospitalizations: inequalities in rates between US socioeconomic groups. Am J Public Health 87 (1997) 811-816